Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Cash Flow Reinvestment Rate
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow Reinvestment Rate of 2.29x as of December 2024, reinvesting CN¥107.98 Million (capex CN¥105.31 Million plus investments CN¥-2.66 Million) from operating cash flow of CN¥47.07 Million. See Suzhou Fushilai Pharmaceutical Co. Ltd. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Suzhou Fushilai Pharmaceutical Co. Ltd. generate cash.
Annual Cash Flow Reinvestment Rate for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Suzhou Fushilai Pharmaceutical Co. Ltd.. See Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.29x | CN¥107.98 Million | CN¥47.07 Million | CN¥105.31 Million | ▲ +60.6% |
| 2023 | 1.43x | CN¥135.38 Million | CN¥94.77 Million | CN¥41.62 Million | ▼ -82.4% |
| 2022 | 8.10x | CN¥1.22 Billion | CN¥151.19 Million | CN¥50.11 Million | ▲ +1358.8% |
| 2021 | 0.56x | CN¥110.87 Million | CN¥199.73 Million | CN¥80.75 Million | ▼ -57.8% |
| 2020 | 1.32x | CN¥219.57 Million | CN¥166.85 Million | CN¥65.69 Million | ▲ +17.6% |
| 2019 | 1.12x | CN¥168.45 Million | CN¥150.55 Million | CN¥70.93 Million | — |